Literature DB >> 23525708

Current outlook of cardiac stem cell therapy towards a clinical application.

Shin-Ichiro Takashima1, Dennie Tempel, Henricus J Duckers.   

Abstract

Keywords:  INTERVENTIONAL CARDIOLOGY; MYOCARDIAL ISCHAEMIA AND INFARCTION (IHD)

Mesh：

Year:  2013        PMID： 23525708     DOI： 10.1136/heartjnl-2012-303308

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  7 in total

Review 1.  Stem cell therapy to treat heart ischaemia: implications for diabetes cardiovascular complications.

Authors:  Abbas Ali Qayyum; Anders Bruun Mathiasen; Jens Kastrup
Journal:  Curr Diab Rep       Date:  2014-12       Impact factor: 4.810

2.  Transcriptional changes in bone marrow stromal cells of patients with heart failure.

Authors:  Izida R Minullina; Nina P Alexeyeva; Sergey V Anisimov; Maxim V Puzanov; Svetlana N Kozlova; Yurii V Sviryaev; Andrey Yu Zaritskey; Eugeniy V Shlyakhto
Journal:  Cell Cycle       Date:  2014-03-11       Impact factor: 4.534

Review 3.  Multipotent stem cells of the heart-do they have therapeutic promise?

Authors:  Camila F Leite; Thalles R Almeida; Carolina S Lopes; Valdo J Dias da Silva
Journal:  Front Physiol       Date:  2015-05-08       Impact factor: 4.566

4.  The transplantation of Akt-overexpressing amniotic fluid-derived mesenchymal stem cells protects the heart against ischemia-reperfusion injury in rabbits.

Authors:  Yan Wang; Yigang Li; Lei Song; Yanyan Li; Shan Jiang; Song Zhang
Journal:  Mol Med Rep       Date:  2016-05-05       Impact factor: 2.952

5.  Myocyte-specific enhancer factor 2c triggers transdifferentiation of adipose tissue-derived stromal cells into spontaneously beating cardiomyocyte-like cells.

Authors:  Shinichiro Takashima; Soichiro Usui; Oto Inoue; Chiaki Goten; Kosei Yamaguchi; Yusuke Takeda; Shihe Cui; Yoshio Sakai; Kenshi Hayashi; Kenji Sakata; Masa-Aki Kawashiri; Masayuki Takamura
Journal:  Sci Rep       Date:  2021-01-15       Impact factor: 4.379

6.  Rationale and design of a prospective, randomised study of retrograde application of bone marrow aspirate concentrate (BMAC) through coronary sinus in patients with congestive heart failure of ischemic etiology (the RETRO study).

Authors:  L Pleva; P Kukla; K Vítková; V Procházka
Journal:  BMC Cardiovasc Disord       Date:  2019-01-31       Impact factor: 2.298

Review 7.  Nanoparticles-Assisted Stem Cell Therapy for Ischemic Heart Disease.

Authors:  Kai Zhu; Jun Li; Yulin Wang; Hao Lai; Chunsheng Wang
Journal:  Stem Cells Int       Date:  2015-12-29       Impact factor: 5.131
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.